Back to Directory
ExoNostic
Greater London
Founded 2023
Semiconductor biosensors for blood-based cancer biomarker detection
ExoNostic is a diagnostic technology company developing semiconductor biosensors for cancer biomarker detection.
Its investigational lab-on-a-chip platform is designed to identify molecular signatures in small blood samples, combining sensor-based measurements with computational interpretation. An Innovate UK-funded programme focuses on point-of-care detection of biomarkers associated with triple-negative breast cancer.
The company is developing a disposable testing concept for clinical and research settings, although its biological recognition chemistry and clinical performance remain to be independently validated.